Prophylactic or Preemptive Infusion Of Donor-Derived CD19 CAR-T Cell Therapy in High-Risk B-Cell Acute Lymphoblastic Leukaemia Following Allogeneic Transplantation: A Post-Hoc Analysis of Two Clinical TrialsWenyi Lu, Mingfeng Zhao, Xin Jin et al.|SSRN Electronic Journal|2023Cited by 0